Navitoclax (ABT-263) [CAS: 923564-51-6]



Catalog-Number: S1001


Navitoclax Research Compound: Pioneering the Future of Cancer Research

Overview: Navitoclax, a potent and selective BCL-2 family inhibitor, is at the forefront of cancer research and therapy. This small-molecule compound is designed for use in various scientific studies, particularly those exploring the pathways of apoptosis and cancer cell survival.
Key Features:
  • Targeted Action: Navitoclax specifically targets key proteins in the BCL-2 family, making it a powerful tool for studying apoptosis in cancer cells.
  • Research-Grade Quality: Our Navitoclax is synthesized to the highest purity standards, ensuring reliable and consistent results in your experiments.
  • Versatile Application: Widely used in oncology research, including studies on lymphomas, leukemias, and solid tumors.
  • Available in Various Quantities: To accommodate different scales of research, we offer Navitoclax in multiple quantity options.

  • Enhanced Research Accuracy: High purity and selectivity of Navitoclax provide precise insights into apoptosis mechanisms and cancer biology.
  • Innovative Cancer Research: Contributes to groundbreaking discoveries in cancer treatment and therapy development.
  • Comprehensive Data Sheet: Each purchase includes a detailed data sheet with storage instructions, molecular structure, and safety information.

Safety Information:
  • For Research Use Only: Not for human or veterinary use.
  • Handling Precautions: Requires careful handling and storage as per the provided guidelines.

Ideal For:
  • Cancer Research Laboratories
  • Molecular Biology and Biochemistry Studies
  • Pharmaceutical Development and Screening
  • Academic and Clinical Research Institutions

Order Now: Unlock the potential of your cancer research with the high-quality Navitoclax research compound. Ensure precise, groundbreaking results in your studies today!

CAS No.: 923564-51-6
Storage: -20°C
Target: Bcl-2, Bcl-w, Bcl-xL